NAD+ regulating composition powder suitable for mammals

TWM687107UActive Publication Date: 2026-09-01JINGYI LIFE TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115204849
Authority / Receiving Office
TW · TW
Patent Type
Utility models
Current Assignee / Owner
Filing Date
2026-05-27
Publication Date
2026-09-01
Estimated Expiration
2036-05-26

Smart Images

  • Figure TWG2TB001909486_001
    Figure TWG2TB001909486_001
  • Figure TWG2TB001909486_002
    Figure TWG2TB001909486_002
  • Figure TWG2TB001909486_003
    Figure TWG2TB001909486_003
Patent Text Reader

Abstract

A powder packet containing an NAD+ regulating composition suitable for mammals includes an outer packaging and a powder composition. The outer packaging defines a closed containment space. The powder composition is disposed within the containment space and includes a compound powder and excipients, the compound powder being composed of NMN, pterostilbene, and apigenin. This increases NAD+ levels and reduces NAD+ loss, thereby enhancing anti-aging effects.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A powder packet of NAD+ regulating composition suitable for mammals, comprising: an outer packaging defining a closed containment space; and a powder composition disposed in the containment space and comprising a compound powder and excipients, the compound powder being composed of NMN, pterostilbene, and apigenin.

2. The NAD+ regulating composition powder packet suitable for mammals as described in claim 1, wherein, The powder composition is 100 wt% by weight, the NMN content is between 0.01 wt% and 10 wt%, the pterostilbene is extracted from blueberries, and the apigenin is extracted from chamomile.

3. The NAD+ regulating composition powder packet suitable for mammals as described in claim 2, wherein, The content of pterostilbene ranges from 0.1wt% to 20wt%.

4. The NAD+ regulating composition powder packet suitable for mammals as described in claim 2, wherein, The content of apigenin ranges from 0.01wt% to 10wt%.

5. The NAD+ regulating composition powder packet suitable for mammals as described in claim 1, wherein, The outer packaging is configured as a bag and includes two sheets, each sheet having a bag body portion and a sealing portion surrounding and connecting the bag body portion, the bag body portions collectively defining the receiving space, and the sealing portions being connected to each other.

6. The NAD+ regulating composition powder packet suitable for mammals as described in claim 5, wherein, These encapsulation portions have at least one tear-off opening.